Diagnostic and treatment of subclinical hypothyroidism in pregnant and planning pregnancy patients: modern view of the problem
https://doi.org/10.14341/probl12687
Abstract
There is no universal diagnostic and treatment strategy of subclinical hypothyroidism (SHT) in pregnant women and those who are planning pregnancy due to differences in population-specific and trimester-specific thyroid-stimulating hormone (TSH) reference values, influence of thyroid autoimmunity markers on pregnancy outcomes, adherence to fixed universal cutoff concentrations TSH in Russia and multidisciplinary team care with different treatment opinions involving. An absence of universal approach to SHT leads to excess treatment, financial and psychological burden on pregnant women.
Up to American Thyroid Association (ATA) Guidelines 2017 and project of Clinical Guidelines of Russian Association of Endocrinologists 2019 a treatment strategy of SHT should be left up to the endocrinologist to choose. In our paper we systematize global scientific and clinical experience of planning and management pregnancies with SHT to help physicians to choose treatment option based on principals of evidence-based medicine.
About the Authors
E. S. ShilovaRussian Federation
Ekaterina S. Shilova.
199034, St. Petersburg, Mendeleyevskaya Line, 3.
eLibrary SPIN: 9703-5970
Competing Interests: No
N. V. Borovik
Russian Federation
Natalya V. Borovik - MD, PhD.
St. Petersburg.
eLibrary SPIN: 9010-7276
Competing Interests: No
P. V. Popova
Russian Federation
Polina V. Popova - MD, PhD.
St. Petersburg.
eLibrary SPIN: 1150-3432
Competing Interests: No
M. I. Yarmolinskaya
Russian Federation
Maria I. Yarmolinskaya - MD, PhD, Professor.
St. Petersburg.
eLibrary SPIN: 3686-3605
Competing Interests: No
References
1. Lazarus J, Brown RS, Daumerie C et al. 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J. 2014;3(2):76-94. doi: 10.1159/000362597
2. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315-89. doi: 10.1089/thy.2016.0457
3. Maraka S, Ospina NM, O’Keeffe DT et al. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016;26(4):580-90. doi: 10.1089/thy.2015.0418
4. Korevaar TIM, Derakhshan A, Taylor PN, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth. JAMA. 2019;322(7):632. doi: https://doi.org/10.1001/jama.2019.10931
5. Chen L, Hu R. Thyroid autoimmunity and miscarriage: a meta-analysis. Clinical Endocrinology. 2011;74(4):513-519. doi: 10.1111/j.1365-2265.2010.03974.x
6. Liu H, Shan Z, Li,C, et al. Maternal Subclinical Hypothyroidism, Thyroid Autoimmunity, and the Risk of Miscarriage: A Prospective Cohort Study. Thyroid. 2014;24(11):1642-1649. doi: 10.1089/thy.2014.0029
7. Seungdamrong A, Steiner AZ, Gracia CR, et al. Eunice Kennedy Shriver National Institute of child health and human development reproductive medicine network. Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertil Steril. 2017;108:843-50. doi: 10.1016/j.fertnstert.2017.08.026
8. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: metaanalysis of evidence. BMJ. 2011;342:d2616. doi: 10.1136/bmj.d2616.
9. Van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Human Reproduction Update. 2011;17(5):605-619. doi: 10.1093/humupd/dmr024
10. Negro R. Thyroid autoimmunity and pre-term delivery: brief review and meta-analysis. J Endocrinol Invest. 2011; 34:155-158. doi: 10.1007/BF03347047.
11. He X, Wang P, Wang Z, He X, et al. Thyroid antibodies and risk of preterm delivery: a metaanalysis of prospective cohort studies. Eur J Endocrinol. 2012;167:455-464. doi: 10.1530/EJE-12-0379.
12. Korevaar TM, Pop VJ, Chaker L, et al. Dose dependency and a functional cutoff for TPO-antibody positivity during pregnancy. J Clin Endocrinol Metab. 2018;103:778-789. doi: 10.1210/jc.2017-01560
13. Dedov II, Melnichenko GA, et al. Clinical Guidelines of Russian Association of Endocrinologists. Hypothyroidism. 2019. (In Russ.). Доступно по: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/gipotireoz.proekt.klin_.rek_3.pdf Ссылка активна на 05.10.20 г.
14. Soldin OP, Tractenberg RE, Hollowell JG, et al. Trimester-Specific Changes in Maternal Thyroid Hormone, Thyrotropin, and Thyroglobulin Concentrations During Gestation: Trends and Associations Across Trimesters in Iodine Sufficiency. Thyroid. 2004;14(12):1084-1090. doi: 10.1089/thy.2004.14.1084
15. Haddow JE, McClain M, Lambert-Messerlian G, et al. Variability in thyroid stimulating hormone suppression by human chronic gonadotropin during early pregnancy. J Clin Endocrinol Metab. 2008;93:3341- 3347. doi: 10.1210/jc.2008-0568
16. Garber JR, Cobin RH, Gharib H, et al. American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. doi: 10.4158/EP12280.GL
17. Elenkov IJ, Wilder RL, Bakalov VK,et al. IL-12, TNF-a, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab. 2001;86(10):4933-4938. doi: 10.1210/jcem.86.10.7905
18. Zimmermann MB. The effects of iodine deficiency in pregnancy and infancy. Paediatr. Perinat Epidemiol. 2012;26(1):108-117. doi: 10.1111/j.1365-3016.2012.01275.x.
19. Soboleva DE, Dora SV, Volkova AR, et al. Iodine status of pregnant women living in Saint Petersburg. The effectiveness of iodine prevention in risk group. Problems of Women Health. 2015;10(2): 25-31. (In Russ.).
20. Benhadi N, et al. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin. Endocrinol. (Oxf.). 2007;66:765-770. doi: 10.1111/j.1365-2265.2007.02803.x
21. Korevaar TI, Steegers EA, de Rijke YB. et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. Clin. Endocrinol. Metab. 2013;98:4382-4390. doi: 10.1210/jc.2013-2855
22. Han C, et al. High body mass index is an indicator of maternal hypothyroidism, hypothyroxinemia, and thyroid-peroxidase antibody positivity during early pregnancy. Biomed. Res. Int. 2015;321831. doi: 10.1155/2015/351831
23. Mosso L, et al. Early pregnancy thyroid hormone reference ranges in Chilean women: the influence of body mass index. Clin. Endocrinol. (Oxf.). 2016;85:942-948. doi: 10.1111/cen.13127
24. Korevaar TI, Steegers EAP, Pop VJ, et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population-based prospective cohort studies. J. Clin. Endocrinol. Metab. 2017;102:69-77. doi: 10.1210/jc.2016-2942
25. Hou Y, Liu A, Li J, et al. Different Thyroidal Responses to Human Chorionic Gonadotropin Under Different Thyroid Peroxidase Antibody and/or Thyroglobulin Antibody Positivity Conditions During the First Half of Pregnancy. Thyroid. 2019 Apr; 29(4):577-585. doi: 10.1089/thy.2018.0097
26. Korevaar TI, Steegers EA, de Rijke YB, et al. Placental angiogenic factors are associated with maternal thyroid function and modify hCG-mediated FT4 stimulation. J. Clin. Endocrinol. Metab. 2015;100:E1328-E2334. doi: 10.1210/jc.2015-2553
27. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011;21(10):1081-1125. doi:10.1089/thy.2011.0087
28. Canovi S, Vezzani S, Polese A, et al. Pregnancy-related reference intervals for serum thyrotropin based on real-life clinical data. Gynecol Endocrinol. 2020;322(7):1-4. doi: https://doi.org/10.1080/09513590.2020.1756251
29. Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab. 2012;97:777-784. doi: 10.1210/jc.2011-2038
30. Li C, Shan Z, Mao J, et al. Assessment of Thyroid Function During First-Trimester Pregnancy: What Is the Rational Upper Limit of Serum TSH During the First Trimester in Chinese Pregnant Women? The Journal of Clinical Endocrinology & Metabolism. 2014;9(1):73-79. doi: 10.1210/jc.2013-1674
31. Medici M, Korevaar TI, Visser WE, et al. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61(5):704-713. doi: 10.1373/clinchem.2014.236646
32. Popova PV, Shilova ES, Tkachuk AS. First Trimester Thyroid Function in Pregnant Women residing in St Petersburg (Russia): Reference Values and Risk of Gestational Diabetes. Diabetes Mellitus. 2018;21(1):34-41. (In Russ.). doi: 10.14341/DM9283
33. Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999;50(5):655-659. doi: 10.1046/j.1365-2265.1999.00719.x
34. Arojoki M, Jokimaa V, Juuti A, et al. Hypothyroidism among infertile women in Finland. Gynecol Endocrinol. 2000;14(2):127-131. doi: 10.3109/09513590009167671
35. Abalovich M, Mitelberg L, Allami C, et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol. 2007;23(5):279-283. doi: 10.1080/09513590701259542
36. Feldthusen AD, Pedersen PL, Larsen J, et al. Impaired fertility associated with subclinical hypothyroidism and thyroid autoimmunity: the Danish General Suburban Population Study. J Pregnancy. 2015;2015:132718. doi: 10.1155/2015/132718
37. Poppe K, Glinoer D, Van Steirteghem A, et al. Thyroid dysfunction and autoimmunity in infertile women. Thyroid. 2002;12(11):997-1001. doi: 10.1089/105072502320908330
38. Plowden TC, Schisterman EF, Sjaarda LA, et al. Subclinical hypothyroidism and thyroid autoimmunity are not associated with fecundity, pregnancy loss, or live birth. J Clin Endocrinol Metab. 2016;101(6):2358-2365. doi: 10.1210/jc.2016-1049
39. Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril. 2015;104(3):545-553. doi: 10.1016/j.fertnstert.2015.05.028
40. Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. N Engl J Med. 2019;380(14):1316-1325. doi: 10.1056/NEJMoa1812537.
41. Kim CH, Ahn JW, Kang SP, et al. Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2011;95(5):1650-1654. doi: 10.1016/j.fertnstert.2010.12.004.
42. Wang H, Gao H, Chi H, et al. Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA. 2017;318(22):2190-2198. doi: 10.1001/jama.2017.18249.
43. Dong AC, Stephenson MD, Stagnaro-Green AS. The Need for Dynamic Clinical Guidelines: A Systematic Review of New Research Published After Release of the 2017 ATA Guidelines on Thyroid Disease During Pregnancy and the Postpartum. Frontiers in Endocrinology. 2020;11. doi: 10.3389/fendo.2020.00193
44. Andersen SL, Andersen S, Liew Z, Vestergaard P, Olsen J. Maternal thyroid function in early pregnancy and neuropsychological performance of the child at 5 years of age. J Clin Endocrinol Metab. 2018;103:660-70. doi: 10.1210/jc.2017-02171
45. Andersen SL, Andersen S, Vestergaard P, Olsen J. Maternal thyroid a Danish Nationwide Case-Cohort Study. Thyroid. 2018;28:537-46. doi: 10.1089/thy.2017.0425
46. Yang J, Liu Y, Liu H, et al. Associations of maternal iodine status and thyroid function with adverse pregnancy outcomes in Henan Province of China. J Trace Elem Med Biol. 2018;47:104-10. doi: 10.1016/j.jtemb.2018.01.013
47. Negro R, Schwartz A, Gismondi R, et al. Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2010;95(9):E44-E48. doi:10.1210/jc.2010-0340
48. Schneuer FJ, Nassar N, Tasevski V, et al. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab. 2012;97(9):3115-3122. doi: 10.1210/jc.2012-1193
49. Wang S, Teng WP, Li JX, et al. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinol Invest. 2012;35(3):322-325. doi: 10.3275/7772
50. Lopez-Tinoco C, Rodriguez-Mengual A, Lara-Barea A, et al. Impact of positive thyroid autoimmunity on pregnant women with subclinical hypothyroidism. Endocrinol Diabetes Nutr. 2018;65:150-5. doi: 10.1016/j.endien.2017.11.020
51. Arbib N, Hadar E, Sneh-Arbib O, et al. First trimester thyroid stimulating hormone as an independent risk factor for adverse pregnancy outcome. J Matern Fetal Neonatal Med. 2017;30:2174-8. doi: 10.1080/14767058.2016.1242123
52. Derakhshan A, Peeters RP, Taylor PN, et al. Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis. The Lancet Diabetes & Endocrinology. 2020;8(6):501-510. doi: 10.1016/s2213-8587(20)30061-9
53. Chen LM, Du WJ, Dai J, et al. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One. 2014;9(10):e109364. doi: 10.1371/journal.pone.0109364
54. Wilson KL, Casey BM, McIntire DD, et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012;119(2Pt1):315-320. doi: 10.1097/AOG.0b013e318240de6a
55. Tudela CM, Casey BM, McIntire DD, et al. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol. 2012;119(5):983-988. doi: 10.1097/AOG.0b013e318250aeeb
56. Nelson SM, Haig C, McConnachie A, et al. Maternal thyroid function and child educational attainment: prospective cohort study. BMJ. 2018;360:k452. doi: 10.1136/bmj.k452
57. Maraka S, Mwangi R, McCoy RG, et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017;356:i6865. doi: 10.1136/bmj.i6865
58. Nazarpour S, Ramezani Tehrani F, Simbar M, et al. Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrine Metab. 2018;103:926-35. doi: 10.1210/jc.2017-0185
59. Casey BM, Thom EA, Peaceman AM, et al. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy. New England Journal of Medicine. 2017;376(9):815-825. doi: 10.1056/nejmoa1606205
60. Lazarus JH, Bestwick JP, Channon S et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366(6):493-501. doi: 10.1056/NEJMoa1106104
61. Zhao L, Jiang G, Tian X, et al. Initiation timing effect of levothyroxine treatment on subclinical hypothyroidism in pregnancy. Gynecol Endocrinol. 2018;34:845-8. doi: 10.1080/09513590.2018.1451836
62. Toloza FJK, Singh Ospina NM, Rodriguez-Gutierrez R, et al. Practice Variation in the Care of Subclinical Hypothyroidism During Pregnancy: A National Survey of Physicians in the United States. J Endocr Soc. 2019;3(10):1892-1906. doi: https://doi.org/10.1210/js.2019-00196
63. Dolgushina NV, Artimuk NV, Belokrinitskaya TE, et al. Clinical Guidelines of Russian Association of Obstetrician and Gynecologist. Physiological Pregnancy. 2019. (In Russ.). Доступно по: https://docviewer.yandex.ru/view/0/?*=nKnu28OZjp5ygElEAiA07g8NBZt7InVybCI6InlhLWRpc2stcHVibGljOi8vVzZJSFh1VWpLdERmSlRIb1IxSjk2UHQvdGRIL1ovL3VXM1dCUFV1WCsrMXVCTkJBVC9mVW9OSjA4VXZaYVJTMnEvSjZicG1SeU9Kb25UM1ZvWG5EYWc9PSIsInRpdGxlIjoi0J3QvtGA0LzQsNC70YzQvdCw0Y8g0LHQtdGA0LXQvNC10L3QvdC%2B0YHRgtGMLmRvY3giLCJub2lmcmFtZSI6ZmFsc2UsInVpZCI6IjAiLCJ0cyI6MTYwMTg5NDU1MDkwOCwieXUiOiI1Mzk2NjAyOTMxNTk5MDMzNjQzIn0%3D Ссылка активна на 05.10.20 г.
Supplementary files
Review
For citations:
Shilova E.S., Borovik N.V., Popova P.V., Yarmolinskaya M.I. Diagnostic and treatment of subclinical hypothyroidism in pregnant and planning pregnancy patients: modern view of the problem. Problems of Endocrinology. 2020;66(6):65-73. (In Russ.) https://doi.org/10.14341/probl12687

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).